Role of cytokines in lipopolysaccharide‐induced functional and structural abnormalities of astrocytes

Glia

Volumn 10, Issue 3, 1994, Pages 227-234

  Hu, Shuxian ^a,b   Martella, Alice ^a,b   Anderson, W Robert ^a,b   Chao, Chun C ^a,b  

^a MINNEAPOLIS MEDICAL RESEARCH FOUNDATION   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

Author keywords

GABA uptake; Glutamine synthetase; Interleukin 1; Interleukin 6; Tumor necrosis factor

Indexed keywords

4 AMINOBUTYRIC ACID; CYTOKINE; DNA; GLUTAMATE AMMONIA LIGASE; GLUTAMIC ACID; GLUTAMIC ACID DERIVATIVE; LIPOPOLYSACCHARIDE;

ANIMAL; ARTICLE; ASTROCYTE; BIOSYNTHESIS; CELL SURVIVAL; DRUG EFFECT; METABOLISM; MOUSE; MOUSE STRAIN; PHYSIOLOGY; ULTRASTRUCTURE;

ANIMAL; ANIMALS, NEWBORN; ASTROCYTES; CELL SURVIVAL; CYTOKINES; DNA; GAMMA-AMINOBUTYRIC ACID; GLUTAMATE-AMMONIA LIGASE; GLUTAMATES; GLUTAMIC ACID; LIPOPOLYSACCHARIDES; MICE; MICE, INBRED BALB C; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0028389345     PISSN: 08941491     EISSN: 10981136     Source Type: Journal    
DOI: 10.1002/glia.440100309     Document Type: Article

References (35)

1. Cerebrospinal fluid cachectin/tumor necrosis factor‐α and platelet‐activating factor concentrations and severity of bacterial meningitis in children
2. Human astrocytes proliferate in response to tumor necrosis factor alpha
3. No direct neurotoxicity by HIV‐1 virions or culture fluids from HIV‐1‐infected T cells or monocytes
4. Compartmentalization of lipopolysaccharide production correlates with clinical presetation in meningococcal disease
5. Cytokine release from microglia: differential inhibition by pentoxifylline and dexamethasone
6. Effects of transforming growth factor‐β on murine astrocyte glutamine synthetase activity: Implications in neuronal injury
7. Tumor necrosis factor‐alpha production by astrocytes: Induction by lipopolysaccharide, interferon‐gamma and interleukin‐1
8. Dual effect of glial maturation factor on astrocytes: Giulian D, Lachman, L. Interleukin‐1 stimulation of astroglial proliferation after brain injury
9. Intracerebral synthesis of tumor necrosis factor‐α and interleukin‐6 in infectious meningitis
10. Interleukin‐1 stimulation of astroglial proliferation after brain injury
11. Role of astrocytes in compartmentation of amino acid and energy metabolism
12. The immunology of sepsis and meningitis‐cytokine biology
13. Cytokine production by human fetal microglia and astrocytes
14. Production of tumor necrosis factor and other cytokines by astrocytes stimulated with lipopolysaccharide or a neurotropic virus
15. Protein measurement with the Folin phenol reagent
16. Glutamine synthetase: Glial localization in brain
17. Endotoxin concentrations in cerebrospinal fluid correlate with clinical severity and neurologic outcome of Haemophilus influenzae type B meningitis
18. Bioactive and inactive forms of tumor necrosis factor‐α in spinal fluid from patients with meningitis
19. Tumor necrosis factor in mediating experimental Haemophilus influenzae type B meningitis
20. Correlation of interleukin‐1β and cachectin concentrations in cerebrospinal fluid and outcome from bacterial meningitis
21. The beneficial effects of early dexamethasone administration in infants and children with bacterial meningitis
22. Tumor necrosis factor α/cachectin and interleukin 1β initiate meningeal inflammation
23. Recombinant human interleukin‐1 induces meningitis and blood‐brain barrier injury in the rat: Characterization and comparison with tumor necrosis factor
24. Bacterial meningitis: pathogenesis, pathophysiology, and progress
25. The role of cytokines in the generation of inflammation and tissue damage in experimental gram‐negative meningitis
26. Production of tumor necrosis factor‐alpha by microglia and astrocytes in culture
27. In vitro production of IL‐6, IL‐1β, and tumor necrosis factor‐α by human embryonic microglial and neural cells
28. Proliferation of astrocytes in vitro in response to cytokines: a primary role for tumor necrosis factor
29. Blood‐brain barrier damage in patients with bacterial meningitis: Association with tumor necrosis factor‐α but not interleukin‐1β
30. Tumor necrosis factor α and interleukin 1 α enhance lipopolysaccharide‐mediated bovine endothelial cell injury
31. Neurologic sequelae of meningitis
32. Treatment of bacterial meningitis: blocking harmful mediators of bacterial and host origin
33. Toxicity in neuronal cells caused by cerebrospinal fluid from pneumococcal and gram‐negative meningitis
34. Partner drugs: a new outlook for bacterial meningitis
35. Local production of tumor necrosis factor α, interleukin 1, and interleukin 6 in meningococcal meningitis